RESEARCH DISCIPLINE
COVID-19 Research Statistical Analysis
Timing, Exposure and Delay in View
For COVID-19 cohorts and surveillance data: exposures such as vaccination and treatment that change over time, outcomes that follow infection and reports that arrive late, with designs that avoid immortal time bias.
No Commitment Required
Strictly Confidential
In-House PhD-Level Statisticians
Fixed Project Fee
Same-Day Response
What Does Statistical Analysis in COVID-19 Research Involve?
COVID-19 research statistical analysis estimates how infection, vaccination, treatment and patient characteristics relate to outcomes such as hospitalization, severe disease, persistent symptoms and death, in cohorts and surveillance data where exposures change over time and reporting lags behind events. It covers the definition of exposure windows and time zero, the handling of time-varying exposure, the sensitivity analysis for reporting delays and the reporting of effects with their uncertainty. OnlineSPSS, a specialist statistical consultancy for academic, clinical and professional research, supports epidemiologists, clinicians and graduate researchers: an in-house PhD-level statistician sets up time zero and the exposure windows in your data and is explicit about what an observational pandemic design can support. The public health and clinical conclusions are yours to draw.
WHEN TO ENGAGE
Where Pandemic Studies Need Statistical Design
The timing of infection, exposure and reporting shapes every pandemic dataset, and statistical input matters most when a cohort is built, exposure shifts, counts arrive or a reviewer objects.
Cohort Being Defined A hospital, registry or health system cohort is being assembled, and the dates of inclusion, the definition of infection and the start of follow-up must be fixed so that exposure groups compare fairly.
Exposure Changing Over Time Vaccination, treatment or infection status changes during follow-up, and the analysis needs a time-varying exposure and a design that does not credit patients with person-time before exposure began.
Surveillance Counts to Interpret Case or death counts by date are to be analyzed, and delays between onset, testing and reporting, shifting testing policies and waves all influence the trend that appears.
Reviewer Raises Bias A reviewer suspects immortal time, testing bias or confounding in an observational comparison, and the response needs a redesigned analysis or a quantified bias, not a rebuttal.
WHAT THE SUPPORT COVERS
Statistical Components of COVID-19 Studies We Support
COVID-19 cohort analysis depends on getting dates right before any model is fitted, and the six areas below run from the cohort rules to the published estimate.
Cohort Definition
Infection, vaccination and outcome dates define time zero, exposure windows and follow-up, and each rule is stated so that others can reconstruct the cohort.
Time-Varying Exposure
Exposures that change are analyzed as time-varying within Survival Analysis, with landmark or trial emulation designs where they fit the question better.
Outcome Models
Hospitalization, severe disease and persistent symptoms are modeled with a model suited to each outcome, adjusted for confounders chosen on clinical and epidemiological grounds.
Policy and Wave Effects
Changes in counts after a measure such as a school closure or a vaccine rollout are studied with Interrupted Time Series, allowing for waves and autocorrelation.
Reporting Delays
Recent counts are incomplete because reports lag, and nowcasting or sensitivity analyses show how the latest weeks may change as the missing reports arrive.
Reporting Observational Studies
Cohort findings are reported under STROBE with estimates and intervals, as expected in Epidemiology and Public Health research.
COMMON ISSUES
Biases Common in Pandemic Observational Data
COVID-19 clinical outcome analysis meets biases from timing, testing and changing variants, and each one needs an answer in the design before an estimate can be trusted.
Immortal Time in Vaccine Studies Person-time before a person was vaccinated is counted as vaccinated, so the vaccinated group appears protected because its members had to survive until vaccination.
Testing Driven by Severity Infected people who are tested are more often the ill, so outcomes among the tested overstate severity, and the true number of infections behind them is unknown.
Waves Treated as One Period Variants, treatments and hospital strain changed across waves, and pooling them hides effects that differ by period and confounds comparisons made across time.
Recent Counts at Face Value The latest days in a surveillance series look as if cases are falling, simply because reports have not yet arrived, and a trend fitted to them inherits the artifact.
Adjusting for the Pathway Conditions that follow exposure are adjusted for as if they were baseline confounders, which can remove part of a real effect or introduce a new bias.
Association Described as Protection A lower risk among vaccinated people is described as the effect of the vaccine without discussing healthy vaccinee bias and differences in exposure to infection.
DELIVERABLES
What You Receive for Your COVID-19 Analysis
Because dates drive every estimate in a pandemic cohort, the files document each derivation from the dated records to the final table.
Cohort Specification A document of the dates, definitions and eligibility rules that create the cohort, with a flow diagram of the patients each rule removed.
Person-Time Analysis Dataset A dataset in the person-time format that the design requires, with exposure periods, event times and a codebook of each derivation.
Exposure Window Estimates Hazard or risk ratios for each exposure window and period, with 95% confidence intervals and the events and person-time behind every estimate, laid out for a journal table.
Delay and Wave Analyses Analyses by period and sensitivity analyses for reporting delays, showing how far the findings depend on when the data were taken.
Trend Figures and Tables Tables and trend figures prepared for a journal, a thesis or a health authority report, with the sample size for each model.
Bias Assessment Notes Notes for each analysis on immortal time, testing patterns and residual confounding, for you to check and incorporate in your own write-up, with the code that produced every estimate.
ILLUSTRATIVE EXAMPLE
Antiviral Treatment and Hospitalization in an Outpatient Cohort
An illustration of how a treatment started after diagnosis is analyzed without crediting the treated with untreated days.
ILLUSTRATIVE EXAMPLE · COVID-19 OUTPATIENT COHORT RESEARCH · UNITED STATES
A clinical epidemiologist wanted to estimate whether outpatients with COVID-19 who received an oral antiviral were hospitalized less often within 28 days than similar patients who did not.
Treatment was not randomized and was often started days after the first positive test. Had everyone been followed from diagnosis, patients who started later would have had to stay out of hospital until they started, favoring the treated group. The plan used a sequential trial emulation, in which patients eligible on each day were classified by whether they started treatment that day, with a prespecified covariate set, and a sensitivity analysis varied the allowed treatment window. Confounding by disease severity and the changing variants were discussed, and the result was described as an adjusted association.
Outcome: The researcher received the adjusted risk ratio with its 95% confidence interval, the cohort flow diagram, the sensitivity analysis, the tables and the scripts, with a note on the remaining risks of bias.
This example does not describe a real client or project. We never share details of actual client work, in line with the confidentiality we promise every researcher. This illustrative example is included to show the type, scope, and standard of work involved in this kind of analysis.
SOFTWARE
Code for Dated Cohorts and Counts
Large record extracts may be prepared in Python or SAS and modeled in R or Stata, with each step scripted so that the cohort can be rebuilt.
HOW WE ASSESS YOUR PROJECT
We Review Your Actual Research
Your assessment is based on a review of your actual research materials and analytical requirements, not a generic project category.
You Submit Your Project Details
Share whatever is available at the current stage, such as the research aim, protocol or proposal, dataset, variable list, manuscript or statistical requirements.
We Review Your Research and Define the Scope
Your statistically trained Research Coordinator reviews the materials to understand the study design, research questions, data structure, analytical requirements and expected deliverables. If clarification is needed, additional documents or information can be requested before the assessment is finalized.
Your Analysis Is Completed and Delivered
Once the scope and fixed project fee are agreed, the in-house statistician completes the work and the Research Coordinator remains the communication point through delivery, with the analysis, deliverables and timeline as agreed.
RESEARCH RESPONSIBILITY
Statistical Support Within Your Own COVID-19 Research
OnlineSPSS supports the timing, the models and the bias checks, while the clinical and public health judgments drawn from them rest with you.
Agreed Statistical Support OnlineSPSS provides the agreed methodological, analytical and statistical reporting support, defined in a scope that is confirmed before any work begins.
No Intellectual Contribution OnlineSPSS does not claim any intellectual contribution to your research. Authorship of the manuscript, thesis or report remains yours.
Your Research Decisions The research question, the clinical and public health interpretation, the discussion and the conclusions remain yours, with overall responsibility.
Confidential Handling Research data and project details are handled confidentially, project information is not published, and an NDA is available where required.
FREQUENTLY ASKED QUESTIONS
Questions About COVID-19 Data Analysis
Immortal time, late-arriving reports and variant waves account for most of the methodological questions in pandemic cohorts.
What does statistical analysis for COVID-19 research cover?
Statistical analysis for COVID-19 research covers cohort definition, time-varying exposures, outcome models, surveillance counts with reporting delays and effects reported with confidence intervals. Records from hospitals, registries and health systems can be used, and the public health reading of the results is left to you.
What is immortal time bias, and could it affect my study?
It arises when the exposed group is credited with follow-up before exposure began, time in which its members had to stay event-free to be counted as exposed, so exposure looks protective. It is common where vaccination or treatment starts after follow-up begins, and it is prevented by design, through time-varying exposure, landmark or trial emulation, not by adjustment.
How should reporting delays in recent case counts be handled?
The latest days in a surveillance series are incomplete, so an apparent decline can be an artifact. Recent counts can be flagged, adjusted by nowcasting based on the usual delay distribution or left out of a trend model, and a sensitivity analysis shows how much the conclusion depends on the choice.
How should waves and variants be handled in one analysis?
Effects may differ by period because variants, treatments and health system strain changed. Analyses can be stratified by period or include an interaction between period and exposure, and whether pooling is justified is itself examined and reported, not assumed.
How do you protect my research data and confidentiality?
Your data and project details are handled confidentially, and project information is not published. Researcher names and institutions are not used publicly without permission. An NDA is available where required and can be arranged before sensitive materials are shared. Read more about confidentiality and data security.
What happens when I request an assessment, and how long does it take?
You share your research question, design and relevant materials, such as a protocol, exposure definitions or a dated dataset, and a statistically trained Research Coordinator reviews the request and responds the same day. The analysis, deliverables, timeline and one fixed project fee are then confirmed before any work begins, so the timeline follows from the agreed scope.
Still have a question? Find more answers in our full FAQ.
NEXT STEP
Map Your Exposure
and Event Dates
Outline your question, how infection, exposure and outcome dates were captured and any reviewer comments, so that the assessment can show where time zero and follow-up would begin in your data.
No Commitment Required
Strictly Confidential
Fixed Project Fee
In-House PhD-Level Statisticians
Same-Day Response
Serving Researchers Since 2014